Pete H. Hutson

782 citations

17 papers · 598 indexed · h-index 12

Cellular and Molecular Neuroscience top 5%
Molecular Biology
Cognitive Neuroscience top 10%
Organic Chemistry
Biochemistry top 10%

Co-authors: Jason M. Uslaner Marlene A. Jacobson Rosemarie B. Flick Sophie Parmentier‐Batteur June Sing Hong Lam Caitlyn McNaughton Sarah Grimwood J.F.W. Deakin
Topics: Neuroscience and Neuropharmacology Research (9 papers)Receptor Mechanisms and Signaling (8 papers)Neurotransmitter Receptor Influence on Behavior (7 papers)
Cited by: Biological Psychiatry Cellular and Molecular Neuroscience Biochemistry
Journals: Biological Psychiatry Brain Research Journal of Neurochemistry
Partner nations: United States United Kingdom Canada

In The Last Decade

Pete H. Hutson

17 papers receiving 587 citations

Peers

Countries citing papers authored by Pete H. Hutson

Since Specialization

Citations

This map shows the geographic impact of Pete H. Hutson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pete H. Hutson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pete H. Hutson more than expected).

Fields of papers citing papers by Pete H. Hutson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pete H. Hutson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pete H. Hutson. The network helps show where Pete H. Hutson may publish in the future.

Co-authorship network of co-authors of Pete H. Hutson

This figure shows the co-authorship network connecting the top 25 collaborators of Pete H. Hutson. A scholar is included among the top collaborators of Pete H. Hutson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pete H. Hutson. Pete H. Hutson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao,Scott T. Harrison,(unknown),John M. Sanders,(unknown),(unknown),Debra A. McLoughlin,Christopher R. Gibson,R. Robinson,Nancy A. Sachs,Monika Kandebo,Lihang Yao,Sean M. Smith,Pete H. Hutson,S. E. Wolkenberg,James C. Barrow	10
2	Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT) 2015 ·ACS Medicinal Chemistry Letters ·Scott T. Harrison,Michael S. Poslusney,(unknown),Zhijian Zhao,Nathan R. Kett,(unknown),Jeffrey Y. Melamed,Timothy J. Allison,Sangita B. Patel,John M. Sanders,Sujata Sharma,Robert F. Smith,Dawn L. Hall,R. Robinson,Nancy A. Sachs,Pete H. Hutson,S. E. Wolkenberg,James C. Barrow	36
3	Selective orexin 2 receptor antagonism blocks cue-induced reinstatement, but not nicotine self-administration or nicotine-induced reinstatement 2014 ·Behavioural Brain Research ·Jason M. Uslaner,Christopher J. Winrow,Anthony L. Gotter,Anthony J. Roecker,Paul J. Coleman,Pete H. Hutson,Anh D. Lê,John J. Renger	32
4	The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task 2011 ·Journal of Neurogenetics ·Joshua D. Vardigan,Antonella Converso,Pete H. Hutson,Jason M. Uslaner	39
5	A Randomized, Double-Blind, Crossover Comparison of MK-0929 and Placebo in the Treatment of Adults With ADHD 2011 ·Journal of Attention Disorders ·(unknown),Robert Alexander,(unknown),Pete H. Hutson,(unknown),Duane Snavely,(unknown),Alan P. Watt,Fred Reimherr,Lenard A. Adler	4
6	3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts 2010 ·Bioorganic & Medicinal Chemistry Letters ·Edward J. Brnardic,Mark E. Fraley,R. M. Garbaccio,M. E. Layton,John M. Sanders,Chris Culberson,Marlene A. Jacobson,Brian C. Magliaro,Pete H. Hutson,Julie A. O’Brien,Sarah L. Huszar,Jason M. Uslaner,Kerry L. Fillgrove,Cuyue Tang,Yuhsin Kuo,(unknown),George D. Hartman	30
7	T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats 2010 ·Neuropharmacology ·Jason M. Uslaner,Sean M. Smith,Sarah L. Huszar,(unknown),(unknown),Joshua D. Vardigan,(unknown),(unknown),Lihang Yao,James C. Barrow,Victor N. Uebele,John J. Renger,Janet Clark,Pete H. Hutson	27
8	Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration 2010 ·Neuropharmacology ·Sophie Parmentier‐Batteur,Julie A. O’Brien,Scott M. Doran,(unknown),Rosemarie B. Flick,Jason M. Uslaner,Hank Chen,(unknown),Theresa M. Williams,Marlene A. Jacobson,Pete H. Hutson	50
9	T-Type Calcium Channel Antagonism Decreases Motivation for Nicotine and Blocks Nicotine- and Cue-Induced Reinstatement for a Response Previously Reinforced with Nicotine 2010 ·Biological Psychiatry ·Jason M. Uslaner,Joshua D. Vardigan,(unknown),Victor N. Uebele,John J. Renger,(unknown),Zhaoxia Li,Anh D. Lê,Pete H. Hutson	13
10	Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 Receptor 2010 ·ACS Medicinal Chemistry Letters ·R. M. Garbaccio,Edward J. Brnardic,Mark E. Fraley,George D. Hartman,Pete H. Hutson,Julie A. O’Brien,Brian C. Magliaro,Jason M. Uslaner,Sarah L. Huszar,Kerry L. Fillgrove,James H. Small,Cuyue Tang,Yuhsin Kuo,Marlene A. Jacobson	14
11	Combined administration of an mGlu2/3 receptor agonist and a 5-HT2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants 2009 ·Psychopharmacology ·Jason M. Uslaner,Sean M. Smith,Sarah L. Huszar,(unknown),(unknown),Joshua D. Vardigan,Pete H. Hutson	25
12	Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus 2009 ·Neuropharmacology ·Jason M. Uslaner,Sophie Parmentier‐Batteur,Rosemarie B. Flick,(unknown),June Sing Hong Lam,Caitlyn McNaughton,Marlene A. Jacobson,Pete H. Hutson	158
13	Inhibition of glycine transporter 1 attenuates nicotine- but not food-induced cue-potentiated reinstatement for a response previously paired with sucrose 2009 ·Behavioural Brain Research ·Jason M. Uslaner,(unknown),(unknown),Cory R. Theberge,Cyrille Sur,Zhizhen Zeng,David L. Williams,Pete H. Hutson	8
14	The discovery of fused pyrrole carboxylic acids as novel, potent d-amino acid oxidase (DAO) inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Tim Sparey,Pravien Abeywickrema,Sarah Almond,Nicholas J. Brandon,Noel Byrne,(unknown),Pete H. Hutson,Marlene A. Jacobson,Brian V. Jones,Sanjeev Munshi,Danette Pascarella,Andrew Pike,G. Sridhar Prasad,Nancy A. Sachs,(unknown),Vinod Sardana,Shankar Venkatraman,Mary Beth Young	63
15	Postnatal development and kinetics of [3H]gaboxadol binding in rat brain: In vitro homogenate binding and quantitative autoradiography 2007 ·Brain Research ·(unknown),Bjarke Ebert,Pete H. Hutson,Peter Brust,K Nieber,Winnie Deuther‐Conrad	11
16	N‐Methyl‐d‐aspartate receptor subtype‐selectivity of homoquinolinate: an electrophysiological and radioligand binding study using both native and recombinant receptors 2002 ·Journal of Neurochemistry ·Sarah Grimwood,Keith A. Wafford,Alison Macaulay,Pete H. Hutson	5
17	NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia 1999 ·Neuroreport ·Sarah Grimwood,P. Slater,J.F.W. Deakin,Pete H. Hutson	73

About Pete H. Hutson

Pete H. Hutson is a scholar working on Biological Psychiatry, Cellular and Molecular Neuroscience and Molecular Biology, having authored 17 papers that have together received 598 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (9 papers), Receptor Mechanisms and Signaling (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). The work is most often cited by research in Biological Psychiatry (59 citations), Cellular and Molecular Neuroscience (319 citations) and Biochemistry (61 citations). Pete H. Hutson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Jason M. Uslaner, Marlene A. Jacobson, Rosemarie B. Flick, Sophie Parmentier‐Batteur, June Sing Hong Lam, Caitlyn McNaughton, Sarah Grimwood, J.F.W. Deakin, P. Slater and Joshua D. Vardigan. Their work appears in journals such as Biological Psychiatry, Brain Research and Journal of Neurochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact